We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Read more about cookies

an image
  • Register
  • Log in
  • Language

Japan: Opportunities in Japan’s Life Science market

Japan’s pharmaceutical and medical device markets are among the largest in the world worth 77 and 37 billion USD respectively and growing at about 0,5 % and 3 % per year. This is a market of major importance to established Swedish pharmaceutical and medical device companies. The Japanese market is highly relevant to most Swedish companies in the industry. The backbone of the market is Japan’s comprehensive compulsory healthcare insurance system financed by insurance premiums, co-payments (typically 10 to 30 %) and taxes.


Document information
Date: 13 Jun 2019
Size: 629.7 KB(pdf)